Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Nanocarrier Designed to Target Drug Delivery to Cancer Cells

By BiotechDaily International staff writers
Posted on 13 Nov 2013
Image: The first-of-its-kind nanostructure is unusual because it can carry a variety of cancer-fighting materials on its double-sided “Janus” surface and within its porous interior Photo courtesy of UC’s Dr. Donglu Shi).
Image: The first-of-its-kind nanostructure is unusual because it can carry a variety of cancer-fighting materials on its double-sided “Janus” surface and within its porous interior Photo courtesy of UC’s Dr. Donglu Shi).
A novel nanostructure can, because of its dual-surface structure, serve as an improved “all-in-one tool” in the fight against cancer.

The nanostructure was developed by a team of international researchers, including those at the University of Cincinnati (UC; OH, USA), and has the potential to improve all-in-one detection, diagnoses, and drug-delivery treatment of cancer cells.

The first-of-its-kind nanostructure is remarkable because it can carry a range of cancer-fighting substance on its double-sided “Janus” surface and within its porous interior. Because of its unique structure, the nanocarrier can do all of the following: (1) Transport cancer-specific detection nanoparticles and biomarkers to a site within the body, e.g., the prostate or the breast. This promises earlier diagnosis than is possible with current applications. (2) Attach fluorescent marker materials to illuminate specific cancer cells, so that they are easier to find for treatment, whether drug delivery or surgery. (3) Deliver anticancer drugs for pinpoint targeted treatment of cancer cells, which should result in few drug side effects. Currently, a cancer treatment such as chemotherapy affects not only cancer cells but healthy cells as well, leading to serious and often incapacitating side effects.

This research’s findings were presented on October 30, 2013, at the annual Materials Science & Technology Conference in Montreal (QC, Canada). The Janus nanostructure is unusual in that, normally, these structures (much smaller than a single cell) have limited surface. This makes is difficult to carry multiple components, e.g., both cancer detection and drug-delivery materials. The Janus nanocomponent, on the other hand, has functionally and chemically distinct surfaces to allow it to carry multiple components in a single assembly and function in an intelligent manner.

“In this effort, we’re using existing basic nanosystems, such as carbon nanotubes, graphene, iron oxides, silica, quantum dots, and polymeric nanomaterials in order to create an all-in-one, multidimensional, and stable nanocarrier that will provide imaging, cell targeting, drug storage and intelligent, controlled drug release,” said UC’s Dr. Donglu Shi, adding that the nanocarrier’s potential is currently greatest for cancers that are close to the body’s surface, such as breast and prostate cancer.

If such nanotechnology can soon become the standard for cancer detection, it promises earlier, more rapid, and more effective diagnosis at lower cost than current technology. The most common technology used today in cancer diagnosis are magnetic resonance imaging (MRI); positron emission tomography (PET); and computed tomography (CT) imaging, however, they are expensive and time-consuming to use.

Furthermore, when it comes to drug delivery, nanotechnology such as the Janus structure would better regulate the drug dose, since that dose would be targeted to cancer cells. In this way, anticancer drugs could be used much more effectively, which would lower the total amount of drug administered.

Related Links:

University of Cincinnati



WATERS CORPORATION

Channels

Genomics/Proteomics

view channel
Image: Exosomes loaded with catalase (shown in red) efficiently interact with neurons (shown in black) to protect them from the effects of Parkinson\'s disease (Photo courtesy of Dr. Elena Batrakova, University of North Carolina).

Exome Delivery of the Anti-Oxidant Catalase Reduces Parkinson's Disease Symptoms in Mouse Model

The exosome delivery of the antioxidant enzyme catalase was shown to dramatically reduce symptoms of Parkinson's disease (PD) in a mouse model. Exosomes are cell-derived vesicles that are present in... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

27 May 2015 - 28 May 2015
02 Jun 2015 - 03 Jun 2015
15 Jun 2015 - 18 Jun 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.